Key result
Photoplethysmography combined with artificial intelligence and mobile health technology provides an innovative solution for the screening, early warning, and integrated management of atrial fibrillation.
Why the study?
Early diagnosis and effective management are important to reduce atrial fibrillation-related adverse events, and photoplethysmography provides an innovative wearable solution for continuous monitoring and integrated AF care.
How can photoplethysmography (PPG) be applied for the screening, diagnosis, and integrated management of atrial fibrillation?
How can photoplethysmography (PPG) be applied for the screening, diagnosis, and integrated management of atrial fibrillation?
Photoplethysmography (PPG) integrated with wearables and AI offers a promising, innovative approach for continuous monitoring and comprehensive management of atrial fibrillation.
PPG wearables may aid AF screening; leaves open prospective validation for integrated care impact.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Early diagnosis and effective management are important to reduce atrial fibrillation-related adverse events. Photoplethysmography (PPG) is often used to assist wearables for continuous electrocardiograph monitoring, which shows its unique value. The development of PPG has provided an innovative solution to AF management. Serial studies of mobile health technology for improving screening and optimized integrated care in atrial fibrillation have explored the application of PPG in screening, diagnosing, early warning, and integrated management in patients with AF. This review summarizes the latest progress of PPG analysis based on artificial intelligence technology and mobile health in AF field in recent years, as well as the limitations of current research and the focus of future research.
No takes yet. Share an insight, caveat, or question.
Tai et al. (2023) conducted a review in Atrial fibrillation. Photoplethysmography (PPG) was evaluated. Photoplethysmography combined with artificial intelligence and mobile health technology provides an innovative solution for the screening, early warning, and integrated management of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: